PRO MEDICUS LIMITED (ASX:PME) shares rose nearly 10% after securing two US deals, with RBC Capital Markets saying the wins counter concerns that AI competitors could weaken long-term demand. The contracts include a $16 million, 7-year deal with TidalHealth and a $28 million, 5-year renewal with Allegheny Health Network. RBC kept its “sector perform” rating and $195 target, saying the deals support traction in Pro Medicus’ cloud imaging platform.
Advertisement Go to Proactive UK Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Advertisement Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Advertisement Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com